| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.40e-10 | 21 | 89 | 6 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 7.10e-10 | 11 | 89 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | cyclosporin A binding | 8.34e-10 | 24 | 89 | 6 | GO:0016018 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.05e-09 | 14 | 89 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 8.97e-08 | 50 | 89 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.28e-07 | 53 | 89 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.12e-07 | 37 | 89 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.12e-07 | 37 | 89 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 7.02e-07 | 38 | 89 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.02e-07 | 38 | 89 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.86e-06 | 46 | 89 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.23e-05 | 262 | 89 | 8 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.73e-05 | 79 | 89 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.27e-04 | 430 | 89 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | isomerase activity | 2.19e-04 | 192 | 89 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.57e-04 | 136 | 89 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.57e-04 | 136 | 89 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 5.41e-04 | 8 | 89 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 5.94e-04 | 152 | 89 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | amide binding | 2.20e-03 | 299 | 89 | 6 | GO:0033218 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.26e-03 | 16 | 89 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | floppase activity | 2.26e-03 | 16 | 89 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.31e-03 | 645 | 89 | 9 | GO:0140640 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.34e-03 | 775 | 89 | 10 | GO:0017111 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.53e-03 | 654 | 89 | 9 | GO:0008233 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 2.61e-03 | 417 | 89 | 7 | GO:0140098 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.54e-03 | 20 | 89 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 3.54e-03 | 20 | 89 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 3.56e-03 | 441 | 89 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.75e-03 | 231 | 89 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 4.12e-03 | 839 | 89 | 10 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 4.16e-03 | 840 | 89 | 10 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.16e-03 | 840 | 89 | 10 | GO:0016818 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.77e-09 | 13 | 90 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.44e-08 | 38 | 90 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.27e-07 | 54 | 90 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.09e-06 | 48 | 90 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.30e-05 | 178 | 90 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.14e-05 | 83 | 90 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | protein folding | 1.02e-04 | 246 | 90 | 7 | GO:0006457 | |
| Domain | Cyclophilin-type_PPIase_CS | 1.50e-08 | 19 | 81 | 5 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 2.61e-08 | 21 | 81 | 5 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 3.36e-08 | 22 | 81 | 5 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 3.36e-08 | 22 | 81 | 5 | PS50072 | |
| Domain | Pro_isomerase | 3.36e-08 | 22 | 81 | 5 | PF00160 | |
| Domain | - | 3.36e-08 | 22 | 81 | 5 | 2.40.100.10 | |
| Domain | Cyclophilin-type_PPIase_dom | 3.36e-08 | 22 | 81 | 5 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 3.36e-08 | 22 | 81 | 5 | PS00170 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.11e-04 | 4 | 81 | 2 | IPR026966 | |
| Domain | Bravo_FIGEY | 1.11e-04 | 4 | 81 | 2 | PF13882 | |
| Domain | DEP | 1.14e-04 | 22 | 81 | 3 | PF00610 | |
| Domain | DEP | 1.14e-04 | 22 | 81 | 3 | PS50186 | |
| Domain | DEP | 1.14e-04 | 22 | 81 | 3 | SM00049 | |
| Domain | DEP_dom | 1.31e-04 | 23 | 81 | 3 | IPR000591 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.69e-08 | 4 | 90 | 3 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.72e-07 | 94 | 90 | 6 | 21542922 | |
| Pubmed | 5.94e-07 | 274 | 90 | 8 | 34244482 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.19e-06 | 440 | 90 | 9 | 34244565 | |
| Pubmed | PIKFYVE DNAJB12 ATP6AP1 AKAP8 TTC28 MYCBP2 SCAF8 MDC1 PUM2 ICE1 DENND4C | 3.11e-06 | 733 | 90 | 11 | 34672954 | |
| Pubmed | DNAJB12 ATP6AP1 CDC42BPA AKAP8 TBC1D30 SCAF8 MDC1 PUM2 MCM5 ICE1 INO80 ANAPC5 KIF20B LRCH3 FAM83B | 6.60e-06 | 1497 | 90 | 15 | 31527615 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 18588951 | ||
| Pubmed | 1.29e-05 | 298 | 90 | 7 | 30737378 | ||
| Pubmed | 1.33e-05 | 18 | 90 | 3 | 18664271 | ||
| Pubmed | 1.34e-05 | 418 | 90 | 8 | 34709266 | ||
| Pubmed | Expression of SIBLINGs and their partner MMPs in salivary glands. | 1.98e-05 | 3 | 90 | 2 | 15329369 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22028665 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9971820 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18447583 | ||
| Pubmed | Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). | 1.98e-05 | 3 | 90 | 2 | 15954904 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22170052 | ||
| Pubmed | 2.99e-05 | 340 | 90 | 7 | 24332808 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PPIAL4D STRBP RBM10 MDC1 PPIAL4A ICE1 THOC2 PPIAL4G KIF20B DDX3X PPIAL4F | 3.61e-05 | 954 | 90 | 11 | 36373674 |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 27855657 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 18429927 | ||
| Pubmed | Structural and functional evolution of the L1 family: are four adhesion molecules better than one? | 3.96e-05 | 4 | 90 | 2 | 10662501 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 22042093 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 7983737 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 26763578 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 17827148 | ||
| Pubmed | An Important Role of Pumilio 1 in Regulating the Development of the Mammalian Female Germline. | 6.59e-05 | 5 | 90 | 2 | 27170441 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.59e-05 | 5 | 90 | 2 | 12629516 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.59e-05 | 5 | 90 | 2 | 11401426 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 18583960 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | AKAP8 MYCBP2 STRBP RBM10 TBK1 MDC1 MCM5 THOC2 SNX9 DDX3X FAM83B | 6.81e-05 | 1024 | 90 | 11 | 24711643 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TTC28 KIAA1217 TBK1 MTMR2 MCM5 ACE SNX9 ARHGAP21 DDX3X FAM83B | 7.29e-05 | 853 | 90 | 10 | 28718761 |
| Pubmed | 9.26e-05 | 407 | 90 | 7 | 12693553 | ||
| Pubmed | PtdIns5P regulation through evolution: roles in membrane trafficking? | 9.87e-05 | 6 | 90 | 2 | 18774718 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 23230272 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 37255478 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.28e-04 | 298 | 90 | 6 | 32353859 | |
| Pubmed | MEPE Localization in the Craniofacial Complex and Function in Tooth Dentin Formation. | 1.38e-04 | 7 | 90 | 2 | 26927967 | |
| Pubmed | EphB regulates L1 phosphorylation during retinocollicular mapping. | 1.38e-04 | 7 | 90 | 2 | 22579729 | |
| Pubmed | 1.58e-04 | 104 | 90 | 4 | 10470851 | ||
| Pubmed | 1.63e-04 | 446 | 90 | 7 | 24255178 | ||
| Pubmed | 1.84e-04 | 8 | 90 | 2 | 16384981 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.90e-04 | 203 | 90 | 5 | 22083510 | |
| Pubmed | 2.83e-04 | 121 | 90 | 4 | 22412018 | ||
| Pubmed | 2.88e-04 | 650 | 90 | 8 | 38777146 | ||
| Pubmed | 2.94e-04 | 10 | 90 | 2 | 29127326 | ||
| Pubmed | Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion. | 2.94e-04 | 10 | 90 | 2 | 37267915 | |
| Pubmed | 3.79e-04 | 513 | 90 | 7 | 25798074 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDC42BPA AKAP8 TTC28 MYCBP2 KIAA1217 ARHGAP21 DENND4C DDX3X FAM83B | 3.95e-04 | 861 | 90 | 9 | 36931259 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | AKAP8 DSG3 PMPCB KIAA1217 MDC1 MCM5 THOC2 KIF20B DDX3X LRCH3 FAM83B | 4.02e-04 | 1257 | 90 | 11 | 36526897 |
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 4.30e-04 | 12 | 90 | 2 | 16701205 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 19861488 | ||
| Pubmed | Neuronal Ig/Caspr recognition promotes the formation of axoaxonic synapses in mouse spinal cord. | 4.30e-04 | 12 | 90 | 2 | 24411736 | |
| Pubmed | 4.30e-04 | 12 | 90 | 2 | 14557543 | ||
| Pubmed | 4.41e-04 | 244 | 90 | 5 | 29884807 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.76e-04 | 533 | 90 | 7 | 30554943 | |
| Pubmed | 5.02e-04 | 251 | 90 | 5 | 29778605 | ||
| Pubmed | 5.07e-04 | 708 | 90 | 8 | 39231216 | ||
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 5.07e-04 | 13 | 90 | 2 | 24559674 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 5.30e-04 | 254 | 90 | 5 | 28431233 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 5.91e-04 | 14 | 90 | 2 | 17389516 | |
| Pubmed | 6.20e-04 | 263 | 90 | 5 | 34702444 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 6.80e-04 | 15 | 90 | 2 | 31285543 | |
| Pubmed | Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. | 6.86e-04 | 269 | 90 | 5 | 30442662 | |
| Pubmed | 7.64e-04 | 754 | 90 | 8 | 35906200 | ||
| Pubmed | 7.76e-04 | 16 | 90 | 2 | 34270554 | ||
| Pubmed | 8.43e-04 | 71 | 90 | 3 | 33541421 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 8.48e-04 | 588 | 90 | 7 | 38580884 | |
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 8.49e-04 | 162 | 90 | 4 | 14743216 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.61e-04 | 283 | 90 | 5 | 30585729 | |
| Pubmed | Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. | 8.78e-04 | 17 | 90 | 2 | 18927546 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.04e-04 | 774 | 90 | 8 | 15302935 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | 9.06e-04 | 431 | 90 | 6 | 33660365 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.00e-03 | 605 | 90 | 7 | 28977666 | |
| Pubmed | 1.01e-03 | 606 | 90 | 7 | 36538041 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.06e-03 | 989 | 90 | 9 | 36424410 | |
| Pubmed | 1.08e-03 | 613 | 90 | 7 | 22268729 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.13e-03 | 175 | 90 | 4 | 25756610 | |
| Pubmed | 1.17e-03 | 453 | 90 | 6 | 29656893 | ||
| Pubmed | 1.18e-03 | 177 | 90 | 4 | 26206133 | ||
| Pubmed | 1.20e-03 | 809 | 90 | 8 | 32129710 | ||
| Pubmed | Recruitment of the human TREX complex to mRNA during splicing. | 1.22e-03 | 20 | 90 | 2 | 15998806 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.27e-03 | 1016 | 90 | 9 | 19056867 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.29e-03 | 462 | 90 | 6 | 31138677 | |
| Pubmed | 1.35e-03 | 21 | 90 | 2 | 26876013 | ||
| Pubmed | 1.35e-03 | 21 | 90 | 2 | 24923560 | ||
| Pubmed | Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes. | 1.42e-03 | 85 | 90 | 3 | 16051665 | |
| Pubmed | 1.45e-03 | 645 | 90 | 7 | 25281560 | ||
| Pubmed | 1.48e-03 | 22 | 90 | 2 | 26589352 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.53e-03 | 190 | 90 | 4 | 15161933 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK5 DNAJB12 CDC42BPA MYCBP2 SCAF8 KIAA1217 TBK1 NLRC5 FOXN3 SNX9 LRCH3 | 1.60e-03 | 1489 | 90 | 11 | 28611215 |
| Pubmed | 1.60e-03 | 847 | 90 | 8 | 35850772 | ||
| Pubmed | 1.62e-03 | 23 | 90 | 2 | 18320585 | ||
| Pubmed | Perioperative genomic profiles using structure-specific oligonucleotide probes. | 1.62e-03 | 23 | 90 | 2 | 19474452 | |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.62e-03 | 89 | 90 | 3 | 27034005 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PIKFYVE DNAJB12 ATP6AP1 TTC28 MYCBP2 PMPCB ALDH1L2 KIAA1217 PUM2 DDX4 FAM83B | 1.66e-03 | 1496 | 90 | 11 | 32877691 |
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.76e-03 | 24 | 90 | 2 | 24625756 | |
| Pubmed | 1.76e-03 | 24 | 90 | 2 | 33705438 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.82e-03 | 1070 | 90 | 9 | 23533145 | |
| Pubmed | 1.89e-03 | 94 | 90 | 3 | 12761501 | ||
| Pubmed | Leber Congenital Amaurosis / Early-Onset Severe Retinal Dystrophy Overview | 1.91e-03 | 25 | 90 | 2 | 30285347 | |
| Cytoband | 1q21.2 | 1.21e-05 | 71 | 90 | 4 | 1q21.2 | |
| Cytoband | 2p22-p21 | 1.06e-04 | 8 | 90 | 2 | 2p22-p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.49e-04 | 404 | 90 | 6 | chr1q21 | |
| Cytoband | 10q23.31 | 2.05e-03 | 34 | 90 | 2 | 10q23.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q34 | 3.56e-03 | 45 | 90 | 2 | chr2q34 | |
| Cytoband | 19p13.1 | 4.04e-03 | 48 | 90 | 2 | 19p13.1 | |
| GeneFamily | SIBLING family | 7.16e-05 | 5 | 49 | 2 | 1279 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 2.92e-06 | 200 | 81 | 7 | M5980 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PIKFYVE VLDLR CDC42BPA TTC28 MYCBP2 SCAF8 GBE1 PUM2 FOXN3 MED13L THOC2 KIF20B | 1.22e-05 | 856 | 81 | 12 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.38e-05 | 466 | 81 | 9 | M13522 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.35e-06 | 184 | 84 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-06 | 187 | 84 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.62e-06 | 190 | 84 | 6 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.72e-06 | 192 | 84 | 6 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 2.12e-06 | 199 | 84 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.18e-06 | 200 | 84 | 6 | 5a5d70bfb6d253f272cc1f8516205fcfe8106291 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-05 | 155 | 84 | 5 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 1.66e-05 | 168 | 84 | 5 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 180 | 84 | 5 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 88 | 84 | 4 | 2075743c7c0b6d74e80464a6bc776206d744d502 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 88 | 84 | 4 | a49319bc97188550e08248973e10c626124c3917 | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Bergmann_Glia_(Slc1a3)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.34e-05 | 88 | 84 | 4 | 14b11249a2b3fa327622897fe74630c2697ea47e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-05 | 183 | 84 | 5 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.85e-05 | 188 | 84 | 5 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 2.85e-05 | 188 | 84 | 5 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.93e-05 | 189 | 84 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 192 | 84 | 5 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-05 | 193 | 84 | 5 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 3.23e-05 | 193 | 84 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-05 | 193 | 84 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-05 | 193 | 84 | 5 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.32e-05 | 194 | 84 | 5 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-05 | 194 | 84 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 3.40e-05 | 195 | 84 | 5 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 3.48e-05 | 196 | 84 | 5 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 3.48e-05 | 196 | 84 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-05 | 197 | 84 | 5 | b2b7f8dc8ca421441e4c99c4f5d18fbc1668d79f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-05 | 197 | 84 | 5 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.74e-05 | 199 | 84 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.74e-05 | 199 | 84 | 5 | 85bb28369e0568b7b3bda095722102fc793f60ef | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.74e-05 | 199 | 84 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.74e-05 | 199 | 84 | 5 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.74e-05 | 199 | 84 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.83e-05 | 200 | 84 | 5 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.83e-05 | 200 | 84 | 5 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.83e-05 | 200 | 84 | 5 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 140 | 84 | 4 | e64f6aa57bc069cfe970089bd1c298433bfaf771 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 1.96e-04 | 152 | 84 | 4 | f944743f40ff6ed3a7a096dd53e12d3526c67c4d | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.11e-04 | 155 | 84 | 4 | e2c901d5c9e42d25d7702e5e8fc19b06f7c817be | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.11e-04 | 155 | 84 | 4 | 5fabe24a784f0be46040ffc886eabd8d5ce78121 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.50e-04 | 162 | 84 | 4 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-04 | 164 | 84 | 4 | 24fdea5113d92b96f56b06dd2449910a3c785e69 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 2.68e-04 | 165 | 84 | 4 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 2.80e-04 | 167 | 84 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.87e-04 | 168 | 84 | 4 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-04 | 168 | 84 | 4 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-04 | 168 | 84 | 4 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 2.93e-04 | 169 | 84 | 4 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-04 | 170 | 84 | 4 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 170 | 84 | 4 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.00e-04 | 170 | 84 | 4 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.00e-04 | 170 | 84 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | normal-na-Lymphocytic_NK-natural_killer_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.07e-04 | 171 | 84 | 4 | d339840626211a7bf1a9eb8f14d6c9509ab05e1c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 172 | 84 | 4 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 172 | 84 | 4 | 709c6b77a7a52b873eefb6caca28a41291d384af | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.21e-04 | 173 | 84 | 4 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.21e-04 | 173 | 84 | 4 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.28e-04 | 174 | 84 | 4 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-04 | 174 | 84 | 4 | 778e0317c0c63fa4efd74114feb760975b819d92 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.28e-04 | 174 | 84 | 4 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.28e-04 | 174 | 84 | 4 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.28e-04 | 174 | 84 | 4 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.28e-04 | 174 | 84 | 4 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 175 | 84 | 4 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 175 | 84 | 4 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 175 | 84 | 4 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 175 | 84 | 4 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 175 | 84 | 4 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-04 | 177 | 84 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-04 | 177 | 84 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-04 | 177 | 84 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.65e-04 | 179 | 84 | 4 | a28a1de500a74c6dcc43481abf9ec0f7e7a300a9 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.72e-04 | 180 | 84 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-04 | 180 | 84 | 4 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-04 | 180 | 84 | 4 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-04 | 180 | 84 | 4 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 3.72e-04 | 180 | 84 | 4 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-04 | 180 | 84 | 4 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 3.80e-04 | 181 | 84 | 4 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 3.80e-04 | 181 | 84 | 4 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.80e-04 | 181 | 84 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.88e-04 | 182 | 84 | 4 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 182 | 84 | 4 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-04 | 182 | 84 | 4 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | CV-Severe-4|CV / Virus stimulation, Condition and Cluster | 3.88e-04 | 182 | 84 | 4 | c19bbc43d97c426aec37414f46f667a19b62a257 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-04 | 183 | 84 | 4 | ed1e0b07475f9951728682ed70b85367cf2a744d | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.79e-07 | 182 | 81 | 8 | 3887_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A | 6.61e-06 | 197 | 81 | 7 | 2361_UP | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.06e-06 | 199 | 81 | 7 | 7030_DN | |
| Drug | 10-bromocarbamazepine | 1.25e-05 | 2 | 81 | 2 | CID000162886 | |
| Disease | lung carcinoma (is_marker_for) | 7.22e-05 | 5 | 80 | 2 | DOID:3905 (is_marker_for) | |
| Disease | polycythemia (is_implicated_in) | 1.08e-04 | 6 | 80 | 2 | DOID:8432 (is_implicated_in) | |
| Disease | MASA syndrome (implicated_via_orthology) | 1.51e-04 | 7 | 80 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | free androgen index | 5.44e-04 | 374 | 80 | 6 | EFO_0007005 | |
| Disease | QT interval | 6.21e-04 | 534 | 80 | 7 | EFO_0004682 | |
| Disease | interstitial lung disease | 8.11e-04 | 67 | 80 | 3 | EFO_0004244 | |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 9.61e-04 | 17 | 80 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | juvenile idiopathic arthritis | 1.08e-03 | 74 | 80 | 3 | EFO_0002609 | |
| Disease | age at menarche | 1.16e-03 | 594 | 80 | 7 | EFO_0004703 | |
| Disease | hippocampal volume | 1.30e-03 | 297 | 80 | 5 | EFO_0005035 | |
| Disease | taurocholate measurement | 1.34e-03 | 20 | 80 | 2 | EFO_0010538 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.38e-03 | 301 | 80 | 5 | DOID:684 (is_marker_for) | |
| Disease | skin hydration measurement | 1.47e-03 | 21 | 80 | 2 | EFO_0009586 | |
| Disease | unipolar depression, neuroticism measurement | 1.93e-03 | 24 | 80 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | reaction time measurement | 2.07e-03 | 658 | 80 | 7 | EFO_0008393 | |
| Disease | Depressive Symptoms | 2.26e-03 | 26 | 80 | 2 | C0086132 | |
| Disease | acute kidney failure (implicated_via_orthology) | 2.44e-03 | 27 | 80 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | chronotype measurement | 2.69e-03 | 882 | 80 | 8 | EFO_0008328 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FGNQNFEESSAYGKA | 416 | Q99814 | |
| FSDSGNTGNFDRGKK | 6 | Q5VTM2 | |
| DGSGSSLGFKASYEE | 501 | Q7Z408 | |
| FEKDRYSGENGDNFN | 21 | Q9NQI0 | |
| FGNRGFSNSRFEDGD | 91 | Q9NQI0 | |
| GFSKRGGYRDGNNSE | 126 | Q9NQI0 | |
| SNEAYKQDGFTDTGA | 211 | P12821 | |
| FDLGSDRNGSFGGQY | 156 | O43823 | |
| GGSIDDGNFQKSGDF | 661 | Q9Y3Q7 | |
| DGNFQKSGDFYTEKG | 666 | Q9Y3Q7 | |
| FINGQFTDADDGKTY | 446 | Q3SY69 | |
| EDNNYKALFGGNGTE | 326 | O95477 | |
| ASYNSDESKDNGNGS | 491 | Q9NZW4 | |
| KEDSSYANVQDGFNG | 26 | Q5VYY1 | |
| DSSRSVGNGFTYQDK | 741 | P98198 | |
| YGATDRSQDDGGENR | 16 | P98175 | |
| SQNVKDGGRYTFEDA | 411 | P49758 | |
| FRKGNFGTRDAETDG | 111 | Q8TB72 | |
| LRAANKSGTGFGESY | 481 | Q9ULG1 | |
| YDAGGSQDDDGSNDR | 756 | Q9UPP5 | |
| EKQSFLQAYGEGSGA | 36 | Q6NTE8 | |
| AESKSNGEEGYGRSL | 286 | Q9UJX4 | |
| FSGGNTGINFEKYDD | 151 | O00571 | |
| STGGTNKDYADGAIS | 771 | P32926 | |
| DAGSRYENEKNNGTA | 86 | O75439 | |
| NGTGDKSIYGEKFDD | 71 | A0A0B4J2A2 | |
| FLQYKQNGGLEDSGS | 446 | Q9NSA2 | |
| YGALDSGFNSVDSGD | 306 | Q96II8 | |
| ASGQGSVKYDSTDQG | 1066 | Q71F56 | |
| QHVGGTKDSEDNYGD | 676 | Q14676 | |
| SEDGSFIGAYAGSKE | 1176 | O00533 | |
| FEGSGYTDLQERGDN | 236 | Q9NQ76 | |
| YSDSFGGDAQADEGQ | 11 | P33992 | |
| FNEDGSFIGQYSGKK | 1266 | Q92823 | |
| NGDSIDSAFFYGKEQ | 506 | Q7Z3F1 | |
| DFDGGQLSFYDANSK | 456 | Q9BXM9 | |
| SNGSALGDRFEGYDN | 511 | Q5T0W9 | |
| GESSSEAGGENYKDA | 1411 | Q14766 | |
| SGKTYTFQGTEENIG | 156 | Q96Q89 | |
| VFTDGSSNGKAAYTG | 466 | P63132 | |
| EKIGGASSRGENSYG | 136 | Q13614 | |
| SSGAAGEDKGRNSFY | 26 | O95237 | |
| GEDKGRNSFYETSSF | 31 | O95237 | |
| NGTGDKSIYGEKFDD | 71 | P0DN26 | |
| VFTDGSSNGKAAYTG | 466 | P63135 | |
| VFTDGSSNGKAAYTG | 466 | Q9BXR3 | |
| YDDGFTSQLGAEGKS | 96 | Q86WI3 | |
| NGTGDKSIYGEKFDD | 71 | A0A075B759 | |
| NGTGDKSIYGEKFDD | 71 | F5H284 | |
| NGTGDKSIYGEKFDD | 71 | Q9Y536 | |
| NGTGDKSIYGEKFDD | 71 | P0DN37 | |
| QARGGKSGAAFYATE | 1856 | Q9Y2I7 | |
| GQAGEFDYSGSQAVK | 436 | P31327 | |
| ENEGGIDKFSRGYES | 61 | Q04446 | |
| GASNFNDQKSSGIEY | 711 | Q9Y2F5 | |
| RFYGQSKDGDEFNNS | 776 | Q9H7D0 | |
| LESYFQSSKSSGGGE | 26 | Q8TDB6 | |
| YGGSGFSKALQEDDD | 26 | O00409 | |
| YEFATKGSQEGSEGS | 366 | O00409 | |
| SANGEAGGESTKGYT | 81 | Q9NXW2 | |
| SGGQSDQGYGSKDEL | 911 | Q5VZ89 | |
| SDQEGDSSFGKYGRN | 211 | P56746 | |
| FTGNIFASSNGKDYG | 566 | Q6ZMT9 | |
| GNETTYEDGHGSRKN | 186 | Q8IWA5 | |
| FDYFEGATSQRKGDN | 1196 | Q9UPN6 | |
| GAGATTFQEYQKTGE | 26 | Q3MIW9 | |
| GEFSDGSNEAGGIYQ | 226 | Q99574 | |
| AGSTKRTNTGEDGQY | 36 | P51513 | |
| GQFSYSEERESGENK | 481 | P56715 | |
| SYFKDSESADAGGAQ | 176 | Q9Y5X1 | |
| AFGKYRDGDFDVTSG | 196 | Q9Y519 | |
| NSDSDLDYGDNGFGA | 1876 | O14513 | |
| AGASGKVTDFNNGTY | 161 | Q96DL1 | |
| DGNNSYDDAGNYIKS | 291 | P19087 | |
| YRQANGSAKKSGGDF | 1776 | Q5T5P2 | |
| VENGSEQGSYDADKG | 56 | Q6PI26 | |
| KDEAGENYSKDQGGR | 66 | Q96SI9 | |
| SAQGFDYGLGNSKGD | 2701 | O75592 | |
| QNGSALKREFSGGSY | 1641 | Q5VT25 | |
| DDGGFESGAYNNSAI | 31 | P51688 | |
| VFTDGSSNGKAAYTG | 466 | P63136 | |
| GSVASNYGISGKDFA | 546 | Q86UP3 | |
| NYGISGKDFADASAS | 551 | Q86UP3 | |
| GTQFDYERGKGESTE | 611 | Q86XI8 | |
| ATGFDGGNKADQLDY | 1076 | Q8NI27 | |
| GEGKDQRGQSIYSTS | 211 | Q96BF3 | |
| VFTDGSSNGKAAYTG | 466 | P10266 | |
| VFTDGSSNGKAAYTG | 466 | P63133 | |
| VFTDGSSNGKAAYTG | 466 | Q9UQG0 | |
| DTLQRTANKESGGGY | 406 | Q9Y2I9 | |
| DFTAYGGVFGNKQDS | 101 | Q15904 | |
| TGDNLVKGSYGFEAE | 71 | A0A0B4J244 | |
| GEAFNKAQAYGELGS | 951 | Q96AY4 | |
| EKCYRNGDSGEGFSQ | 311 | A6NK53 | |
| IQFSYKDEENGNRGG | 76 | Q5T5U3 | |
| GEDGQSVYKLTDFGA | 146 | Q9UHD2 | |
| DGENEAVYGANKFTG | 661 | P98155 | |
| FSDGSRYEGEFAQGK | 56 | Q8NDC4 |